Leg And Back Pain Relief Tablet
NDC Package 43689-0013-2
Package Information
Leg And Back Pain Relief (capsicum annuum, colocynthis, gnaphalium polycephalum, magnesia phosphorica) tablets is • Adults and children 12 years and above: Dissolve 2 tablets under tongue 2 to 3 times daily or as directed by a physician• Children under 12: Consult a physician• Take at least 10 minutes before or after eating or drinking. This formulation utilizes a tablet delivery system. Marketed by The Magni Company, this product is identified by NDC 43689-0013.
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
- Vegetable Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 43689 - The Magni Company
- 43689-0013 - Leg And Back Pain Relief
- 43689-0013-2 - 1 BOTTLE in 1 CARTON / 125 TABLET in 1 BOTTLE (43689-0013-1)
- 43689-0013 - Leg And Back Pain Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43689-0013-2 identifies a specific commercial package of 1 bottle in 1 carton / 125 tablet in 1 bottle (43689-0013-1) of Leg And Back Pain Relief, a human over the counter drug labeled by The Magni Company. This tablet is formulated for oral use and contains capsicum; citrullus colocynthis fruit pulp; magnesium phosphate, dibasic trihydrate; pseudognaphalium obtusifolium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Magni Company on June 11, 2015. The current certification is valid through December 31, 2027.
How is this The Magni Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43689001302. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.